Information center / / / /

Drug rapidly shrinks metastatic breast cancers in mice

Crucially, the drug appears to be selective, only killing cancer cells and not healthy cells. Photo: Pexels

(James Kingsland/ Medical News Today) –– Every year, around 255,000 women and 2,300 men in the United States receive a diagnosis of breast cancer.

Approximately three-quarters of cases are a type called estrogen receptor-positive, in which the cancer cells have a receptor in their membranes that binds to the sex hormone estrogen. This type of breast cancer is incurable if it spreads.

The problem with current drug treatments, such as tamoxifen, is that the cancer cells can develop resistance. Scientists from the University of Illinois Urbana-Champaign are working on a new type of drug that could prevent the development of resistance. (…)

[button href=”” arrow=”true” new_tab=”true”]read full story[/button]: